| 000 | 03412nam a22003975i 4500 | ||
|---|---|---|---|
| 001 | 76384 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040222.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s2006 gw | s |||| 0|eng d | ||
| 020 | _a9783540376330 | ||
| 024 | 7 |
_a10.1007/3-540-37633-X _2doi |
|
| 050 | 4 |
_aQP552.H5 _bH577 2006 EB |
|
| 082 | 0 | 4 | _a572 |
| 245 | 0 | 4 |
_aThe Histone Code and Beyond : _bNew Approaches to Cancer Therapy _cedited by S. L. Berger, O. Nakanishi, B. Haendler |
| 260 |
_aBerlin, Heidelberg _bSpringer International Publishing _c2006 |
||
| 300 |
_a1 recurso en línea (XIV, 209 p.) _b36 ilustraciones |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 1 |
_aErnst Schering Research Foundation Workshop _x0947-6075 _v57 |
|
| 505 | 0 | _aThe Role of Histone Modifications in Epigenetic Transitions During Normal and Perturbed Development -- Nucleosome Structure and Function -- The Role of Snf2-Related Proteins in Cancer -- Imitation Switch Complexes -- How Is Epigenetic Information on Chromatin Inherited After DNA Replication? -- Polycomb Silencing Mechanisms and Genomic Programming -- CpG Island Methylation and Histone Modifications: Biology and Clinical Significance -- Histone Post-Translational Modifications Regulate Transcription and Silent Chromatin in Saccharomyces cerevisiae -- Histone Acetylation-Mediated Chromatin Compaction During Mouse Spermatogenesis -- Role of Ubiquitin-Like Proteins in Transcriptional Regulation -- Interplay of the SUMO and MAP Kinase Pathways | |
| 520 | 3 | _aMethylation of DNA at cytosine residues as well as post-translational modifications of histones, including phosphorylation, acetylation, methylation and ubiquitylation, contribute to the epigenetic information carried by chromatin. These changes play an important role in the regulation of gene expression by modulating the access of regulatory factors to the DNA. The use of a combination of biochemical, genetic and structural approaches has allowed demonstration of the role of chromatin structure in transcriptional control. The structure of nucleosomes has been elucidated and enzymes involved in DNA or histone modifications have been extensively characterized. Since deregulation of epigenetic marks has been reported in many cancers, a better understanding of the underlying molecular mechanisms bears the promise that new drug targets may soon be found. The newest developments in this quickly developing field are presented in this book | |
| 942 |
_2lcc _cLE |
||
| 988 | _aEBOOK, EBSPRINGERrevisando | ||
| 650 | 7 |
_aHistonas _9145787 _0comprobar BNE19922525497 _2embne |
|
| 650 | 7 |
_aOncología _0comprobar BNE19900969554 _2embne _9139207 |
|
| 700 | 1 |
_aBerger, S. L. _eeditor literario _985426 _0Local |
|
| 700 | 1 |
_aNakanishi, O. _eeditor literario _985427 _0Local |
|
| 700 | 1 |
_aHaendler, B. _eeditor literario _0Local _985428 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/3-540-37633-X _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9783540376330 | ||
| 907 |
_a.b12820027 _b10-10-17 _c01-10-14 |
||
| 998 |
_am _a_alco _a_vill _b26-05-17 _cm _dz _ek _feng _ggw _h4 |
||
| 945 |
_aQP552.H5 H577 2006 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11549245 _z06-04-17 |
||
| 999 |
_c76384 _d76384 _x1 |
||